Cigna Group (The)

The Cigna Group delivered a strong third quarter for fiscal 2025, beating Wall Street expectations on both the top and bottom lines as its Evernorth Health Services segment continued to power growth across the enterprise. Adjusted earnings came in at $7.83 per share, clearing the consensus estimate of $7.64 by 2.47%, while revenue climbed 9.5% year-over-year to $69.75 billion, topping the $66.74 billion estimate by 4.50%. The primary driver behind the outperformance was Evernorth, where pharmacy benefit services and specialty pharmacy volume growth pushed segment adjusted revenues up 15% to $60.39 billion, more than offsetting softer results in the Cigna Healthcare segment following the March 2025 divestiture of Medicare-related businesses to HCSC. Total pharmacy customers grew 4% to 122.5 million, underscoring the company's expanding scale in health services. Cigna also introduced a new rebate-free pharmacy benefit model aimed at improving cost transparency, signaling continued strategic investment in the segment. Management reaffirmed its full-year 2025 adjusted EPS outlook of at least $29.60 per share, providing investors with confidence heading into the final quarter.